Sanofi Increase Decrease Through Net Exchange Differences Other Provisions
Sanofi (SNY) reported Increase Decrease Through Net Exchange Differences Other Provisions of -EUR 259.00 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-02-17.
Financial Statements › Notes
ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions · last filed 2026-02-17
| Period end | Increase Decrease Through Net Exchange Differences Other Provisions 6 month | Increase Decrease Through Net Exchange Differences Other Provisions 12 month | Increase Decrease Through Net Exchange Differences Other Provisions 12 month as first filed |
|---|---|---|---|
| 2025-12-31 | -259.00M EUR 20-F · filed 2026-02-17 | ||
| 2025-06-30 | -255.00M EUR 6-K · filed 2025-10-27 | ||
| 2024-12-31 | 116.00M EUR 20-F · filed 2026-02-17 | ||
| 2024-06-30 | 1.00M EUR 6-K · filed 2024-07-25 | ||
| 2023-12-31 | -65.00M EUR 20-F · filed 2026-02-17 | ||
| 2023-06-30 | -39.00M EUR 6-K · filed 2023-07-28 | ||
| 2022-12-31 | 113.00M EUR 20-F · filed 2025-02-13 | ||
| 2022-06-30 | 154.00M EUR 6-K · filed 2022-07-28 | ||
| 2021-12-31 | 145.00M EUR 20-F · filed 2024-02-23 | ||
| 2021-06-30 | 67.00M EUR 6-K · filed 2021-07-29 | ||
| 2020-12-31 | -214.00M EUR 20-F · filed 2023-02-24 | ||
| 2020-06-30 | -51.00M EUR 6-K · filed 2020-07-29 | ||
| 2019-12-31 | 50.00M EUR 20-F · filed 2022-02-23 | ||
| 2018-12-31 | 50.00M EUR 20-F · filed 2021-03-04 | ||
| 2017-12-31 | -245.00M EUR 20-F · filed 2020-03-05 | -345.00M EUR 20-F/A · filed 2018-03-16 | |
| 2016-12-31 | 36.00M EUR 20-F · filed 2019-03-08 | 61.00M EUR 20-F/A · filed 2018-03-16 | |
| 2015-12-31 | 190.00M EUR 20-F/A · filed 2018-03-16 |